Evaluation of the Efficacy and Safety of Nano-S1
NCT05822180
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
116
Enrollment
NETWORK
Sponsor class
Conditions
COVID-19 Pneumonia
Interventions
DRUG:
NANOS1 , argent colloïdal ,
Sponsor
General Administration of Military Health, Tunisia